Logs: Bennett Institute
The following is a list of all job requests run via OpenSAFELY by Bennett Institute users.
| Status | Project | Workspace | Request ID | Backend | Jobs | User | Started | View request |
|---|---|---|---|---|---|---|---|---|
| Succeeded | OpenSAFELY Internal | unknown-codes-investigation | 12712 | TPP | 1/1 | Milan Wiedemann | 3 years, 1 month ago 26 October 2022 15:47:48 UTC | View, Job request 12712 |
| Succeeded | Ethnicity Short Data Report | ethnicity-short-data-report-notebook | 12710 | TPP | 1/1 | Colm Andrews | 3 years, 1 month ago 26 October 2022 15:40:14 UTC | View, Job request 12710 |
| Failed | OpenSAFELY Internal | unknown-codes-investigation | 12709 | TPP | 0/1 | Milan Wiedemann | 3 years, 1 month ago 26 October 2022 15:31:37 UTC | View, Job request 12709 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12708 | TPP | 2/2 | Bang Zheng | 3 years, 1 month ago 26 October 2022 15:23:22 UTC | View, Job request 12708 |
| Succeeded | OpenSAFELY Internal | unknown-codes-investigation | 12703 | TPP | 2/2 | Milan Wiedemann | 3 years, 1 month ago 26 October 2022 13:16:10 UTC | View, Job request 12703 |
| Failed | OpenSAFELY Internal | unknown-codes-investigation | 12696 | TPP | 1/5 | Milan Wiedemann | 3 years, 1 month ago 26 October 2022 11:50:52 UTC | View, Job request 12696 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12694 | TPP | 1/2 | Bang Zheng | 3 years, 1 month ago 26 October 2022 10:41:04 UTC | View, Job request 12694 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12692 | TPP | 0/1 | Bang Zheng | 3 years, 1 month ago 26 October 2022 10:05:09 UTC | View, Job request 12692 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12691 | TPP | 1/1 | Bang Zheng | 3 years, 1 month ago 26 October 2022 09:59:54 UTC | View, Job request 12691 |
| Succeeded | COVID-19 Vaccine Effectiveness | comparative-booster_main | 12687 | TPP | 12/12 | Will Hulme | 3 years, 1 month ago 26 October 2022 06:12:10 UTC | View, Job request 12687 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12685 | TPP | 0/1 | Bang Zheng | 3 years, 1 month ago 25 October 2022 22:12:15 UTC | View, Job request 12685 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12683 | TPP | 1/1 | Bang Zheng | 3 years, 1 month ago 25 October 2022 21:55:05 UTC | View, Job request 12683 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12682 | TPP | 0/1 | Bang Zheng | 3 years, 1 month ago 25 October 2022 21:47:13 UTC | View, Job request 12682 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12681 | TPP | 0/1 | Bang Zheng | 3 years, 1 month ago 25 October 2022 21:31:18 UTC | View, Job request 12681 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12680 | TPP | 0/1 | Bang Zheng | 3 years, 1 month ago 25 October 2022 21:17:19 UTC | View, Job request 12680 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12677 | TPP | 1/2 | Bang Zheng | 3 years, 1 month ago 25 October 2022 18:12:01 UTC | View, Job request 12677 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12673 | TPP | 2/2 | Bang Zheng | 3 years, 1 month ago 25 October 2022 17:17:50 UTC | View, Job request 12673 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12672 | TPP | 0/2 | Bang Zheng | 3 years, 1 month ago 25 October 2022 16:57:47 UTC | View, Job request 12672 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12671 | TPP | 1/1 | Bang Zheng | 3 years, 1 month ago 25 October 2022 15:41:03 UTC | View, Job request 12671 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12668 | TPP | 1/1 | Bang Zheng | 3 years, 1 month ago 25 October 2022 15:22:01 UTC | View, Job request 12668 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12666 | TPP | 0/1 | Bang Zheng | 3 years, 1 month ago 25 October 2022 15:05:09 UTC | View, Job request 12666 |
| Succeeded | OpenSAFELY Internal | unknown-codes-investigation | 12657 | TPP | 4/4 | Peter Inglesby | 3 years, 1 month ago 25 October 2022 10:41:10 UTC | View, Job request 12657 |
| Failed | COVID-19 Vaccine Effectiveness | comparative-booster_main | 12655 | TPP | 96/113 | Will Hulme | 3 years, 1 month ago 25 October 2022 09:13:04 UTC | View, Job request 12655 |
| Failed | COVID-19 Vaccine Effectiveness | comparative-booster_main | 12653 | TPP | 0/3 | Will Hulme | 3 years, 1 month ago 25 October 2022 08:50:00 UTC | View, Job request 12653 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12648 | TPP | 1/1 | Bang Zheng | 3 years, 1 month ago 24 October 2022 21:36:55 UTC | View, Job request 12648 |